Anebulo Pharmaceuticals Inc. (ANEB) NASDAQ
$2.68 (0.10) (-3.60%)
Market Cap: $71.26M
As of 04/22/24 04:00 PM EDT. Market closed.
Anebulo Pharmaceuticals Inc. (ANEB)
NASDAQ
$2.68
(0.10) (-3.60%)
Market Cap: $71.26M
As of 04/22/24 04:00 PM EDT. Market closed.
Add to Portfolio
... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
PRICE CHART FOR ANEBULO PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$2.78
Days Range
$2.68 - $2.77
52 week range
$1.62 - $4.05
Volume
1,495
Avg. Volume (30 days)
5,955
Market Cap
$71.26M
Dividend Yield
-
P/E
-
Shares Outstanding
25,633,217
Open
-
Previous Close
$2.78
Days Range
$2.68 - $2.77
52 week range
$1.62 - $4.05
Volume
1,495
Avg. Volume (30 days)
5,955
Market Cap
$71.26M
Dividend Yield
-
P/E
-
Shares Outstanding
25,633,217
FINANCIAL STATEMENTS FOR ANEBULO PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ANEBULO PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| English Aron R. | Director | Sep 28, 2022 | Option Exercise | $2.81 | 1,703,577 | 4,787,051 | 5,066,290 | Sep 30, 2022, 09:36 PM |
| English Aron R. | Director | Dec 17, 2021 | Buy | $6.59 | 400 | 2,634 | 3,362,713 | Dec 21, 2021, 08:39 PM |
| English Aron R. | Director | Dec 14, 2021 | Buy | $5.89 | 412 | 2,429 | 3,362,313 | Dec 16, 2021, 11:37 AM |
| English Aron R. | Director | Dec 03, 2021 | Buy | $5.93 | 4,500 | 26,685 | 3,361,901 | Dec 03, 2021, 07:58 PM |
| English Aron R. | Director | Dec 02, 2021 | Buy | $5.30 | 13,836 | 73,331 | 3,357,401 | Dec 03, 2021, 11:16 AM |
| English Aron R. | Director | May 06, 2021 | Option Exercise | $7.00 | 714,250 | 4,999,750 | 3,343,565 | May 17, 2021, 09:47 PM |
| English Aron R. | Director | May 06, 2021 | Option Exercise | $7.00 | 714,286 | 5,000,002 | 3,343,601 | May 07, 2021, 07:23 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| English Aron R. | Director | 09/28/2022 | 4,787,051 |
| English Aron R. | Director | 12/17/2021 | 2,634 |
| English Aron R. | Director | 12/14/2021 | 2,429 |
| English Aron R. | Director | 12/03/2021 | 26,685 |
| English Aron R. | Director | 12/02/2021 | 73,331 |
| English Aron R. | Director | 05/06/2021 | 4,999,750 |
| English Aron R. | Director | 05/06/2021 | 5,000,002 |
FUNDS WITH A POSITION IN ANEBULO PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 4,145 | 0% | -1.14% | Other |
CHANGE IN SHARES OUTSTANDING FOR ANEBULO PHARMACEUTICALS INC
STOCK BUYBACKS FOR ANEBULO PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.61%
1Q
06/30/2023
0.62%
2Q
03/31/2023
0.61%
3Q
12/31/2022
0.61%
4Q
09/30/2022
10.13%
5Q
06/30/2022
10.47%
6Q
03/31/2022
10.47%
7Q
12/31/2021
10.47%
8Q
09/30/2021
10.47%
9Q
06/30/2021
89.45%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ANEBULO PHARMACEUTICALS INC
LOADING...